Background-The vein of Marshall (VOM) is an attractive target during ablation of atrial fibrillation because of its autonomic innervation, its location anterior to the left pulmonary veins, and its drainage in the coronary sinus. Methods and Results-We studied 17 dogs. A coronary sinus venogram showed a VOM in 13, which was successfully cannulated with an angioplasty wire and balloon. In 5 dogs, electroanatomical maps of the left atrium were performed at baseline and after ethanol infusion in the VOM, which demonstrated a new crescent-shaped scar, extending from the annular left atrium toward the posterior wall and left pulmonary veins. In 4 other dogs, effective refractory periods (ERP) were measured at 3 sites in the left atrium, before and after high-frequency bilateral vagal stimulation. 
committee of the Methodist Hospital Research Institute. The protocol adhered to the Public Health Service guidelines for the care and use of laboratory animals. Dogs were premedicated by an intramuscular injection of xylazine (0.75 to 1.5 mg/kg) and atropine, anesthesized by intravenous injection of propofol (5 mg/kg), and continued on isoflurane inhalation for the duration of the study. The left internal jugular and right femoral veins were cannulated. An 8.5-F sheath was advanced into the coronary sinus under fluoroscopic guidance, and a coronary sinus contrast venogram was obtained by occluding its ostium with a balloon catheter.
Initial studies were used to develop a reliable technique of VOM cannulation. After multiple strategies were attempted, selective cannulation of the VOM was reliably achieved by introducing a left internal mammary artery (LIMA) catheter in the coronary sinus, engaging the VOM ostium. Through the LIMA catheter, an angioplasty wire and balloon catheter (2ϫ8 mm) were advanced into the VOM. The balloon was inflated at the ostium of the VOM and selective VOM venograms were obtained. Substantial anatomic variations were present in the length and caliber of the VOM ( Figure  1 ). Electrophysiological evaluations were performed before and after VOM ethanol infusion, following the protocols described later. The angioplasty balloon was then inflated at the ostium of the VOM and 5 cc of 100% ethanol were delivered over 2 minutes through the balloon lumen.
Protocol 1: Extent of Left Atrial Tissue Ablation by Retrograde VOM Ethanol Infusion
After securing cannulation of the VOM with the angioplasty wire and balloon, we performed a trans-septal puncture from the right femoral vein. A sheath was advanced into the left atrium, through which a 3-dimensional mapping catheter (CARTO, BiosenseWebster, Diamond Bar, Calif) was maneuvered to generate a volume rendition of the left atrium and quantify regional amplitudes of the bipolar voltage signals. After a baseline map was obtained, ethanol was injected in the VOM. Five to 10 minutes after ethanol injection, a repeat 3-dimensional voltage map was performed to delineate the extent and distribution of tissue ablated (areas of low-voltage postablation). Complete pre-and postethanol infusion maps were obtained in 5 dogs. In 3 dogs, a third voltage map of the left atrium was performed 30 minutes after completion of the initial map to assess the persistence of the lesions.
Protocol 2: VOM Ethanol Infusion and Parasympathetic Control in the Left Atrium
Because the ligament of Marshall has been implicated as a parasympathetic conduit, 7 we evaluated the effects of ethanol injection in the parasympathetic modulation of the left atrium in 4 dogs. Similar to protocol 1, after securing the cannulation of the VOM, we performed a trans-septal puncture form the right femoral vein. A sheath was advanced into the left atrium, through which a multielectrode basket catheter (Constellation, EP Technologies) was inserted and expanded. Bilateral cervical dissections were performed to expose the vagus trunk. Cuff electrodes were positioned in each vagus nerve and were connected to a Grass stimulator. High-frequency vagal stimulation was titrated to achieve 30% to 50% decrease in heart rate. Left atrial effective refractory periods (ERP) were measured at 3 left atrial sites with and without vagal stimulation, and both before and after VOM ethanol infusion. The basket catheter was pushed toward the lateral atrial wall so that contact close to the VOM region was obtained. One pacing site was chosen from such region, and the other 2 from equidistant splines, as determined by tissue contact and capture.
Induction of AF during vagal stimulation was performed by burst pacing before and after ethanol infusion. Pacing from 3 different atrial sites was performed, starting at a cycle length of 300 ms and decreasing approximately every 5 seconds by 10 ms until loss of 1:1 capture or AF induction. Five induction attempts were performed from each site. If AF persisted more than 1 minute, it was considered sustained, and vagal stimulation was discontinued to allow return of normal sinus rhythm. Mean AF cycle length was quantified by averaging beat-to-beat intervals from selected atrial sites.
Human Feasibility Studies
The human protocol was approved by the Institutional Review Board at the Methodist Hospital and all subjects signed an informed consent form describing the experimental nature of the study. Patients subjected to ablation of AF were included in the study. After obtaining routine intravenous access, an 8-F sheath was advanced into the coronary sinus under fluoroscopy. A balloon occlusion venogram was performed to delineate the coronary sinus anatomy. The presence of the VOM was established when a posteriorly directed vein branch was visible in the right anterior oblique projection. An angiographic LIMA catheter was then inserted in the coronary sinus aiming its tip toward the VOM, and an angioplasty wire was advanced over the VOM. An angioplasty balloon was then advanced over the wire and placed in the proximal VOM.
We then proceeded with obtaining double trans-septal access under intracardiac echocardiographic guidance. A baseline 3-dimensional map of the left atrial geometry and bipolar voltage amplitudes was constructed using either the CARTO (BiosenseWebster) or the NavX-EnSite (St Jude Medical) systems.
Subsequently, we inflated the angioplasty balloon in the proximal VOM as defined by radiographic contrast injection. To ascertain flow in the VOM, 1 mL of echocardiographic contrast agent (Definity) was delivered via the lumen of the angioplasty balloon. Afterward, we performed 2 infusions of 1 cc each of 100% ethanol, 2 minutes apart. We then repeated a 3-dimensional bipolar voltage map of the left atrium to define the tissue areas ablated by ethanol. Finally, conventional radiofrequency ablation of the pulmonary vein antra was performed. Pacing in the coronary sinus was performed to assess for peri-mitral conduction block after ethanol infusion.
Data Analysis
Data are presented as meanϮSD. To compare ERP before and after vagal stimulation, we used the paired t test. To compare ERP before and after vagal stimulation, before and after VOM ethanol infusion, we used repeated-measures ANOVA with the Bonferroni test for multiple comparisons. A probability value Ͻ0.05 was considered significant.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results

Animal Studies
VOM Characteristics and Cannulation
A visible VOM was present in 13 of 17 dogs, identified as a posteriorly directed branch of the coronary sinus in the right anterior oblique fluoroscopic view. Figure 1 shows representative appearances of the VOM.
In 4 dogs, there was no discernable VOM. In the remainder, the length of the VOM was variable (29.7Ϯ10.7 mm) and so was its caliber. In all dogs, the vein communicated with the left atrial lumen, as shown by the presence of contrast in the left atrium via venous collaterals in the left atrial appendage. In 1 dog, a large VOM communicated with the innominate vein as a persistent left superior vena cava ( Figure 1D ).
Successful cannulation of the vein with an angioplasty wire was performed in 11 dogs. After several tools and strategies were attempted, the most reliable technique to cannulate the VOM involved advancing an angiographic left internal mammary (LIMA) catheter in the coronary sinus, so that its tip faced upwards, in contact with the roof of the coronary sinus. Two angioplasty wires were used: 1 was advanced in the lumen of the coronary sinus for fluoroscopic reference and 1 into the VOM through the LIMA catheter, with a preloaded angioplasty balloon (8 mm long, 2-mm diameter). The angioplasty wire (most commonly a Cross-It 0.014-inch wire) was then advanced through the LIMA catheter at different points of the roof of the coronary sinus, probing it at different locations until it could be advanced in the VOM. The wire was advanced in the VOM for a length of 25.4Ϯ11.7 mm from the vein ostium.
Once enough wire was advanced in the VOM, the angioplasty balloon was advanced over the wire into the proximal VOM. Contrast was injected through the balloon lumen to confirm VOM cannulation. The balloon was then inflated to maintain it in place while we proceeded with the experimental protocol. Direct contrast injection via the angioplasty balloon lumen demonstrated the full extent of the VOM and consistently some degree of myocardial staining. In 2 dogs, the length and caliber of the VOM significantly enlarged after selective contrast injection via the balloon (Figure 2A ). Despite balloon inflation to achieve 2-mm diameters, complete occlusion of the VOM was never achieved, and contrast leakage into the coronary sinus lumen was consistently present.
Extent of Endocardial Tissue Ablated
At baseline, 3-dimensional maps demonstrated that bipolar voltage signals in the left atrium exceeded 2 mV in all dogs, consistent with normal healthy tissue. Infusion of 5 cc of 100% ethanol in the VOM was performed over 2 minutes and was not associated with hemodynamic or heart rate changes (in 1 dog that did not have a discernable VOM, rapid ethanol bolus infusion in the main coronary sinus was associated with ST-segment elevation and cardiac arrest). Immediately after ethanol infusion, a repeat bipolar voltage map was performed. This consistently demonstrated a new area of low voltage in the region corresponding to the VOM, extending from the mitral annulus, posteriorly and superiorly toward the left PV. The low-voltage area measured 4.1Ϯ2.7 cm 2 using a threshold of Ͻ1 mV, and 2.2Ϯ1.7 cm 2 using a threshold of Ͻ0.5 mV. Figure 2 shows a typical example. In Figure 2A , the angiographic appearance of the VOM is shown, with significant enlargement of the vein after cannulation and angioplasty balloon inflation. Figure 2B The low-voltage surface areas were variable in extent and distribution, depending on the course, size, and length of the VOM. Figures 2 through 4 show different examples. In Figure 3 , the lesion extends mostly toward the posterior wall of the left atrium in between the left and right PV.
In some cases, the extension of the ablation lesions was small. In Figure 4 , 2 examples are shown where small lesions were created: Figure 4A shows an example of a very small VOM in which cannulation with an angioplasty balloon was only possible in its very proximal portion; and Figure 4B shows a case where a communication between VOM and the innominate vein was present (persistent left superior vena cava), and the lesion size was also small because of ethanol shunting to the central venous circulation.
Lesions were persistent over time. In 3 dogs, repeat voltage maps were performed 30 minutes after completion of the initial map and no significant differences were found. Figure  5 shows the endocardial and epicardial appearance of the lesions after extraction of the heart.
Vagal Denervation by VOM Ethanol Infusion: Effects on AF Induction ERP were measured at 3 atrial sites via basket electrodes before and after vagal stimulation. A decrease in ERP was demonstrable after vagal stimulation. After ethanol infusion, a significant blunting of vagally-mediated decrease in ERP was found ( Figure 6 ). However, this effect was not uniform across the 3 left atrial sites tested; only sites in the neighborhood of the ablated tissue exhibited blunting of the vagal effect ( Figure 6B ).
Sustained AF during vagal stimulation was uniformly inducible (nϭ4 dogs) after burst pacing in 3 atrial sites (37 of 45 attempts). In 1 dog, AF organized into atrial flutter before spontaneous return of sinus rhythm. After VOM ethanol infusion, AF was induced in 19 of 45 attempts (PϽ0.001). Mean cycle length of AF after VOM ethanol infusion was slightly longer after VOM ethanol infusion (118.8Ϯ22.3 versus 111.3Ϯ19.2 ms at baseline, PϽ0.05). Organization into atrial flutter was present in 2 of 4 dogs after VOM ethanol infusion.
Left Atrial Propagation Patterns and Perimitral Conduction After VOM Ethanol Infusion
It has been suggested that the ligament of Marshall participates in the electric communication between the right and left atria, as the terminal component of the interatrial communication via the coronary sinus. 9 We evaluated left atrial activation maps before and after VOM ethanol infusion and were unable to show appreciable differences in left atrial activation patterns. Similarly, there were no changes in perimitral conduction patterns after VOM ethanol infusion.
Human Feasibility Studies
Nine patients were consented for the study. In 2 patients there was no visible VOM in the coronary sinus venogram. In 1 patient, a small coronary sinus dissection was created during 
Procedural Impact
The total added procedure time (including coronary sinus cannulation and venogram, VOM cannulation, balloon occlusion and ethanol infusion, and repeat 3-dimensional voltage map) was 52.6Ϯ12.8 minutes (range, 31 to 66 minutes), and the added fluoroscopy time was 8.2Ϯ2.8 minutes (range, 4.1 to 10 minutes). There was no evidence of mitral annular conduction block after VOM ethanol infusion. In all 6 patients, ethanol levels measured at the end of the procedure in venous blood from the femoral vein were undetectable. In Figure 6 . VOM ethanol infusion abolishes vagally-mediated decreases in ERPs. A, ERPs measured in 3 left atrial sites before and after VOM ethanol infusion showed blunting of vagal decreases in ERP after VOM ethanol infusion. This was particularly obvious at sites fluoroscopically adjacent to the VOM (B). 4 of 6 patients, the left inferior PV became electrically disconnected solely with ethanol infusion (in 1 of 6 patients, the left superior PV as well). The total radiofrequency ablation times required to achieve left inferior PV isolation in the 2 patients that required it were 0.8 and 4.6 minutes. On follow-up, 1 patient was taken back for atrial flutter caused by macro-reentry in the right PV antrum, remote to areas affected by VOM ethanol infusion and likely unrelated to the VOM procedure. This was successfully ablated by radiofrequency application in the septal aspect of the right superior PV, and remains in normal sinus rhythm. All other patients remain in normal rhythm as well.
Discussion
The major findings of our study are as follows: (1) the VOM is a viable route to deliver therapeutic agents into left atrial tissues; (2) retrograde VOM ethanol infusion leads to tissue ablation in areas of the left atrium routinely targeted during catheter ablation of AF; (3) regional parasympathetic ablation is achieved by retrograde VOM ethanol infusion; and (4) retrograde VOM ethanol infusion is feasible in humans.
VOM as a Therapeutic Target in AF
The ligament of Marshall has been solidly implicated in arrhythmogenesis. Scherlag et al 10 demonstrated an inducible ectopic rhythm arising from the ligament area on left cardiac sympathetic nerve stimulation. Doshi et al 11 went on to specifically demonstrate the role of the ligament of Marshall in such adrenergic atrial tachycardia. A wealth of clinical data supports the VOM as a source of ectopic foci driving the genesis and maintenance of AF. [12] [13] [14] [15] [16] [17] Mechanistically, there are electric connections between left superior pulmonary vein, left atrium, and ligament of Marshall. 18 In addition, focal ectopy arising in the VOM triggering AF has been demonstrated clinically 5, 16 and in experimental models of AF. 20 The ligament of Marshall contains parasympathetic 7 and sympathetic 6 innervation 19 that mediate autonomic modulation of the left atrial tissue and have been implicated in the pathogenesis of AF. 8 Ulphani et al 7 have shown that ablation of the ligament of Marshall blunts the vagally mediated decreases in left atrial ERP. We show that similar effects are achieved via retrograde VOM ethanol infusion.
VOM Ethanol Infusion for Left Atrial Ablation
The aforementioned data support the VOM as a target of ablation in its own right from the mechanistic standpoint. Two additional facts support targeting the VOM: (1) the thick pectinate muscle between the left atrial appendage and left-sided PV can be difficult to ablate using current techniques, and it is precisely the course of the VOM on the epicardial side 2 ; and (2) the posterior wall of the left atrium in the vicinity of the VOM can also be close to the esophagus, and current ablation techniques entail risk of esophageal damage and atrioesophageal fistula, which can be deadly.
Cannulating the VOM allows delivery of therapeutic agents in left atrial tissue. The anatomic distribution of tissues reached includes not only the vein and associated innervation, but also areas routinely targeted during catheter ablation of AF. Ethanol infusion leads to effective tissue ablation in these areas, as limited by the size and extent of the VOM. Ethanol is routinely used to ablate tissue in hypertrophic cardiomyopathy, 21 and occasionally ventricular tachycardias that do not respond to conventional RF ablation. 22 In these instances, ethanol is delivered arterially. Besides direct toxic effects, ethanol-induced arterial sclerosis is thought to mediate tissue damage through ischemia, a mechanism absent when retrogradely delivered. Nevertheless, we found adequate tissue ablation from the electric standpoint by retrograde venous infusion. Transmyocardial communication between the epicardial VOM and the left atrial endocardium must have occurred for the toxic effects of ethanol to take place. Contrast leakage into the left atrial lumen was consistently demonstrable during selective VOM venograms. This was confirmed by the human data showing echocardiographic contrast in the left atrium when selectively injected in the VOM. Therefore, transmyocardial transit occurs. It should be emphasized that electroanatomic voltage maps showing tissue ablation by voltage criteria were obtained endocardially, whereas the VOM is an epicardial structure.
Ethanol infusion in the VOM is attractive in ablation of AF because local toxicity of ethanol would be limited to tissues in direct contact with it and would spare neighboring structures such as the esophagus, potentially increasing safety of the procedure. Second, VOM ethanol infusion would directly address mechanistic sources of AF located in the VOM such as autonomic nerves and ectopic foci triggering AF. Third, it could help in achieving adequate ablation of the lateral ridge from the epicardial side. Fourth, a large area of tissue could be ablated at once with a simple infusion, potentially saving procedural time. Furthermore, if performed in isolation, it would be a purely right-sided procedure, obviating the need for a trans-septal puncture and anticoagulation, which are significant sources of procedural complications. Although several surgical reports have reported some efficacy of similarly limited left atrial interventions. 23, 24 most included pulmonary vein isolation as well, and we do not anticipate isolated ethanol VOM infusion as a stand alone procedure, even if it achieved significant vagal denervation. 25 
Conclusions
Retrograde ethanol infusion in the VOM leads to left atrial tissue and vagal ablation and is feasible in humans. Further studies are needed to evaluate its potential role in ablation of AF.
CLINICAL PERSPECTIVE
The vein of Marshall is an atrial branch of the coronary sinus that runs posteriorly and superiorly in the left atrium, anterior to the left pulmonary veins, and posterior to the left atrial appendage. It contains sympathetic and parasympathetic innervation implicated in the pathogenesis of atrial fibrillation. Its location and innervation make it an attractive target in catheter ablation of atrial fibrillation. We hypothesized that we could cannulate the vein of Marshall via the coronary sinus and that retrograde ethanol delivery in such a vein could achieve regional tissue ablation and vagal denervation. We developed a technique for such a purpose and demonstrated in dogs its effectiveness at achieving left atrial tissue ablation. Furthermore, regional vagal denervation in the left atrium was also achieved. We go on to demonstrate that the technique is feasible in humans and show in patients undergoing conventional catheter ablation of atrial fibrillation that retrograde ethanol infusion is well tolerated and leads to left atrial tissue ablation in areas commonly targeted in the ablation procedure. Further studies are required to delineate the role, if any, of retrograde ethanol infusion in the vein of Marshall in the catheter-based treatment of atrial fibrillation.
